D.E. Shaw & Co’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Buy
+3,300
New +$194K ﹤0.01% 4357

Other funds holding ATEX

D.E. Shaw & Co's ATEX Position: Q2 2026 in Review

D.E. Shaw & Co increased its Anterix (ATEX) stake by 1,533% in Q2 2026, buying an estimated $5.12M and bringing the position to 92,990 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

D.E. Shaw & Co first reported a position in ATEX in Q2 2018 and has held it in 32 quarters since. The position peaked at $10.4M in Q3 2024. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • D.E. Shaw & Co held 92,990 shares of Anterix worth $9.57M as of Q2 2026.
  • D.E. Shaw & Co bought 87,294 Anterix shares in Q2 2026, an estimated $5.12M.
  • Anterix made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1847 holding.
  • D.E. Shaw & Co first reported a position in Anterix in Q2 2018 and has held it in 32 quarters since.
  • D.E. Shaw & Co's Anterix position peaked at $10.4M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.